Tumor Treg upregulated glucocorticoid-induced tumor necrosis factor receptor (GITR) expression. Treatment with soluble GITR ligand (GITRL) induced a reduction of inhibition mediated by activated tumor infiltrating Treg and restored the proliferation and cytokine production of CD4+ CD25-T cells. The gene discussed is TNFRSF18; the disease is neoplasm.